Exponent (NASDAQ:EXPO) Rating Lowered to Sell at StockNews.com

Exponent (NASDAQ:EXPOGet Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a report issued on Friday.

Separately, Truist Financial lowered their price target on Exponent from $110.00 to $95.00 and set a “buy” rating on the stock in a report on Friday, February 2nd.

View Our Latest Stock Analysis on EXPO

Exponent Stock Performance

Exponent stock opened at $77.76 on Friday. Exponent has a fifty-two week low of $64.61 and a fifty-two week high of $108.85. The company has a market capitalization of $3.93 billion, a P/E ratio of 39.88 and a beta of 0.72. The stock has a 50-day simple moving average of $86.34 and a 200-day simple moving average of $85.41.

Exponent (NASDAQ:EXPOGet Free Report) last posted its quarterly earnings data on Thursday, February 1st. The business services provider reported $0.41 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.03). The company had revenue of $113.87 million for the quarter, compared to analysts’ expectations of $119.11 million. Exponent had a net margin of 18.69% and a return on equity of 28.49%. The firm’s revenue was up 1.1% on a year-over-year basis. During the same period in the prior year, the company earned $0.44 earnings per share. As a group, analysts forecast that Exponent will post 1.76 earnings per share for the current year.

Insider Buying and Selling

In other news, insider Eric Guyer sold 3,367 shares of the firm’s stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $78.49, for a total transaction of $264,275.83. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, VP Bradley A. James sold 600 shares of the company’s stock in a transaction that occurred on Wednesday, November 22nd. The shares were sold at an average price of $78.98, for a total transaction of $47,388.00. Following the completion of the sale, the vice president now owns 6,984 shares of the company’s stock, valued at approximately $551,596.32. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Eric Guyer sold 3,367 shares of the company’s stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $78.49, for a total transaction of $264,275.83. The disclosure for this sale can be found here. Insiders sold 5,967 shares of company stock valued at $468,164 over the last quarter. Corporate insiders own 2.20% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Neuberger Berman Group LLC grew its stake in Exponent by 2.1% during the fourth quarter. Neuberger Berman Group LLC now owns 2,630,411 shares of the business services provider’s stock valued at $231,581,000 after acquiring an additional 55,036 shares in the last quarter. US Bancorp DE grew its stake in Exponent by 3.2% in the 4th quarter. US Bancorp DE now owns 17,561 shares of the business services provider’s stock worth $1,547,000 after buying an additional 549 shares in the last quarter. PineStone Asset Management Inc. boosted its stake in shares of Exponent by 6.7% in the 4th quarter. PineStone Asset Management Inc. now owns 109,700 shares of the business services provider’s stock valued at $9,658,000 after purchasing an additional 6,900 shares in the last quarter. UBS Group AG boosted its stake in shares of Exponent by 41.4% in the 4th quarter. UBS Group AG now owns 76,565 shares of the business services provider’s stock valued at $6,741,000 after purchasing an additional 22,410 shares in the last quarter. Finally, Norges Bank bought a new stake in Exponent during the 4th quarter valued at $45,786,000. 89.31% of the stock is owned by institutional investors.

Exponent Company Profile

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.